ClinicalTrials.Veeva

Menu

A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status and phase

Completed
Phase 2

Conditions

Vitamin D Deficiency

Treatments

Drug: MK0822A

Study type

Interventional

Funder types

Industry

Identifiers

NCT00242476
2005_089
MK0822A-009
0822A-009

Details and patient eligibility

About

This study will assess the effectiveness of an investigational drug in elderly subjects with low vitamin D levels.

Enrollment

216 patients

Sex

All

Ages

70+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Man or a woman 70 years old or older in general good health

Exclusion criteria

  • Having any form of neurological impairments that may impair motor function.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems